TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34366380

Group type: EXPERIMENTAL
Intervention: Foslevodopa/foscarbidopa administered via abdominal SC infusion over 72 hours
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Foslevodopa/foscarbidopa infusion
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Foslevodopa/foscarbidopa
Number of subjects: 28
Study: 32481510

Group type: EXPERIMENTAL
Intervention: Stockosorb® (STS) at 0.3% mixed with soil + root
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psyllium seed mucilage (PSM) at 0.3% mixed with soil + root
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psyllium seed mucilage (PSM) at 0.1% mixed with soil + root
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psyllium seed mucilage (PSM) at 0.1% and 0.2% mixed with soil + root
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stockosorb® (STS) at 0.2% mixed with soil + root
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stockosorb® (STS) mixed with soil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no hydrophilic polymers)
Number of subjects: 0
Study: 34446067

Group type: EXPERIMENTAL
Intervention: HMB 3 gm/day
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: EPA 2 gm/day
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: HMB plus EPA
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 32186521

Group type: EXPERIMENTAL
Intervention: Philips' Guardian system (mean NPS score 8.8, SD 0.89)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: eTrAC system (mean NPS score 7.7 for nurses, mean NPS score 9.2 for patients)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall NPS scores
Number of subjects: 37
Study: 33333055

Group type: EXPERIMENTAL
Intervention: CA19-9 levels assessed in subjects at risk for pancreatic cancer
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: CA19-9 levels assessed in subjects with resectable pancreatic cancer
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Combination of CA19-9 with LRG1 and TIMP1
Number of subjects: 175
Study: 33036655

Group type: EXPERIMENTAL
Intervention: CBT-I delivered via smartphone application proACT-S
Number of subjects: 285

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 285
Study: 34097005

Group type: EXPERIMENTAL
Intervention: Local Excision (LE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total Mesorectal Excision (TME)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Completion TME
Number of subjects: 0
Study: 32697889

Group type: EXPERIMENTAL
Intervention: SCThrive intervention (six weekly group sessions, in-person booster session, companion app usage)
Number of subjects: 53

Group type: COMPARATOR
Intervention: SCHealthEd intervention (six weekly phone calls on SCD-related and general health education topics)
Number of subjects: 53
Study: 35908849

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gabapentin/montelukast (GBT/MTL)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Dextromethorphan (DXM)
Number of subjects: 180
Study: 33836405

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control
Number of subjects: 132
Study: 35753247

Group type: EXPERIMENTAL
Intervention: 100% pure oxygen inhalation (hyperoxic CHRS testing)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cold face test (CFT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cold pressor test (CPT)
Number of subjects: 10
Study: 34171465

Group type: EXPERIMENTAL
Intervention: Biportal endoscopic technique transforaminal lumbar interbody fusion (BE‐TLIF)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Microscopic tubular technique transforaminal lumbar interbody fusion (MT‐TLIF)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both BE‐TLIF and MT‐TLIF
Number of subjects: 102
Study: 35048150

Group type: EXPERIMENTAL
Intervention: Nanofat mixed with platelet-rich plasma (PRP) infiltrations (2 at 3-month intervals)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical corticosteroid therapy
Number of subjects: 20
Study: 34618511

Group type: EXPERIMENTAL
Intervention: Adapted Screening, Education, and Brief Intervention (Adapted SBI)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Screening and Education with Attention Control (SEA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Both conditions (Adapted SBI and SEA)
Number of subjects: 58
Study: 32699919

Group type: EXPERIMENTAL
Intervention: 4-strand semitendinosus (4ST) graft with adjustable femoral and tibial cortical fixation
Number of subjects: 60

Group type: COMPARATOR
Intervention: ST/gracilis (ST/G) graft with femoral pin transfixation and tibial bioscrew fixation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4-strand semitendinosus (4ST) graft
Number of subjects: 60

Group type: COMPARATOR
Intervention: ST/gracilis (ST/G) graft
Number of subjects: 60
Study: 34852266

Group type: EXPERIMENTAL
Intervention: Minimal fresh gas flow (FGF) sevoflurane anesthesia (0.5 L.min−1)
Number of subjects: 204

Group type: COMPARATOR
Intervention: High fresh gas flow (FGF) sevoflurane anesthesia (2.0 L.min−1)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Minimal fresh gas flow (FGF) sevoflurane anesthesia
Number of subjects: 204
Study: 33208708

Group type: EXPERIMENTAL
Intervention: Venlafaxine (VF, 150-375 mg/d)
Number of subjects: 234
Study: 32854000

Group type: EXPERIMENTAL
Intervention: Abstinence-reinforcing contingency management (CM) intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control
Number of subjects: 73
Study: 35088752

Group type: EXPERIMENTAL
Intervention: Continuous stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1 minute on:1 minute off
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1 minute on:2 minutes off
Number of subjects: 20
Study: 33191117

Group type: EXPERIMENTAL
Intervention: Multiparametric magnetic resonance imaging (MRI) at 3 months from enrollment, followed by fusion-target biopsy if positive (PIRADS-v2>2).
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group underwent PRIAS protocol including a confirmatory 12-core random biopsy at 12 months.
Number of subjects: 124
Study: 32626890

Group type: EXPERIMENTAL
Intervention: Non-surgical flap group
Number of subjects: 98

Group type: COMPARATOR
Intervention: Surgical flap group
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 98
Study: 34903403

Group type: EXPERIMENTAL
Intervention: Training program based on health belief model (6 sessions)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no training during the study)
Number of subjects: 64
Study: 34129365

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2737
Study: 33109394

Group type: EXPERIMENTAL
Intervention: Standard smoking cessation treatment + enhanced cue‐based treatment (interactive texting and cue management counseling)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard smoking cessation treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Standard smoking cessation treatment + enhanced cue‐based treatment
Number of subjects: 24
Study: 36375975

Group type: EXPERIMENTAL
Intervention: GRRAND intervention (physiotherapy programme)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8
Study: 32062371

Group type: EXPERIMENTAL
Intervention: Low dose hydrocortisone (LDH 10 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 35085319

Group type: EXPERIMENTAL
Intervention: Quality nutrition service delivery during ANC
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Good logistical readiness of the facilities
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Consultation by paramedics
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Consultation by community health care providers
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: HCPs' knowledge on maternal nutrition
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Better HCP‐client communication
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Use of visual aids or ANC card
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: HCP training and external supervision
Number of subjects: 1242
Study: 32284387

Group type: EXPERIMENTAL
Intervention: Self-management education support programme (2-day group course plus nurse-led consultation and follow-up over 8 weeks)
Number of subjects: 689

Group type: COMPARATOR
Intervention: Usual care and relaxation programme
Number of subjects: 689
Study: 36224692

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.025 μg/(kg·min)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.050 μg/(kg·min)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.075 μg/(kg·min)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.100 μg/(kg·min)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.125 μg/(kg·min)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 200
Study: 32584367

Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine (T-DM1) plus capecitabine (at phase 1 MTD of 700 mg/m2)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Trastuzumab emtansine (T-DM1) alone
Number of subjects: 161
Study: 35020932

Group type: EXPERIMENTAL
Intervention: SmartBar (260 kcal, 7E% fat, 74E% carbohydrate, 19E% protein)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standardized mixed meal (498 kcal, 34E% fat, 49E% carbohydrate, 17E% protein)
Number of subjects: 14
Study: 34836179

Group type: EXPERIMENTAL
Intervention: Western‐like diet high‐fat (WDHF) meal
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Western‐like diet high-carbohydrate (WDHC) meal
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Mediterranean‐like diet (MED) meal
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: APOE E4 carriers
Number of subjects: 49
Study: 35012592

Group type: EXPERIMENTAL
Intervention: PPE with FFP2 mask with an expiration valve
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PPE with FFP2 mask without an expiration valve
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (without PPE)
Number of subjects: 48
Study: 32903062

Group type: COMPARATOR
Intervention: White light emitting diodes
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Green light emitting diodes
Number of subjects: 29
Study: 36449836

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25% glucose
Number of subjects: 30
Study: 33418429

Group type: EXPERIMENTAL
Intervention: Low-level MAP (60–70 mmHg)
Number of subjects: 322

Group type: COMPARATOR
Intervention: High-level MAP (90–100 mmHg)
Number of subjects: 322
Study: 34216466

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine infiltration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard subcutaneous infiltration of dilute lidocaine solution
Number of subjects: 50
Study: 32354366

Group type: EXPERIMENTAL
Intervention: Newborn CRP levels measured in cord blood
Number of subjects: 358

Group type: COMPARATOR
Intervention: Maternal CRP levels measured during each trimester
Number of subjects: 358

Group type: COMPARATOR
Intervention: Randomization to low dose aspirin prior to pregnancy
Number of subjects: 358
Study: 36089738

Group type: EXPERIMENTAL
Intervention: Personalized music intervention (listening to music of their choice for 30 minutes per session, three times per week for 5 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait-list control (no music for relaxation)
Number of subjects: 42
Study: 34372746

Group type: EXPERIMENTAL
Intervention: New prolonged-release leuprorelin acetate microspheres for injection (3.75 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Enantone® (3.75 mg)
Number of subjects: 48
Study: 36030888

Group type: EXPERIMENTAL
Intervention: Endocuff Vision (ECV)
Number of subjects: 1416

Group type: COMPARATOR
Intervention: High-definition colonoscopies (control)
Number of subjects: 1416
Study: 34952874

Group type: EXPERIMENTAL
Intervention: Management of otitis media in Aboriginal and Torres Strait Islander children
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Research teams' long-term responsibility to deliver benefits to AMSs and communities
Number of subjects: 67
Study: 33052400

Group type: EXPERIMENTAL
Intervention: 5 mg intravenous tropisetron before anesthesia induction
Number of subjects: 1508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1508
Study: 35322769

Group type: EXPERIMENTAL
Intervention: Lurasidone (40 or 80 mg/day)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 33145643

Group type: EXPERIMENTAL
Intervention: Animal HP (high-protein diet with predominance of animal protein)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vegetable HP (high-protein diet with predominance of vegetable protein)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Animal NP (normal protein diet with predominance of animal protein)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vegetable NP (normal protein diet with predominance of vegetable protein)
Number of subjects: 80
Study: 36152382

Group type: EXPERIMENTAL
Intervention: Poor sleep quality
Number of subjects: 2767

Group type: EXPERIMENTAL
Intervention: Poor sleep quality and assigned sex (male)
Number of subjects: 2767
Study: 33099812

Group type: EXPERIMENTAL
Intervention: TACE combined with HIFU (observation group)
Number of subjects: 132

Group type: COMPARATOR
Intervention: TACE alone (control group)
Number of subjects: 132
Study: 32669121

Group type: EXPERIMENTAL
Intervention: Surgical fixation using volar locking plates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-surgical treatment using closed reduction and plaster immobilisation
Number of subjects: 0
Study: 35057420

Group type: EXPERIMENTAL
Intervention: K-diet (traditional balanced Korean diet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet (westernized Korean control diet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: K-diet
Number of subjects: 0
Study: 35690316

Group type: EXPERIMENTAL
Intervention: Phosphodiesterase‐5 inhibitors (PDE‐5i)
Number of subjects: 0
Study: 33506054

Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment for 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: CRSwNP patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TGF‐β1 and IL‐4 in cultured nasal tissues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TGF‐β1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal polyp tissue of CRSwNP
Number of subjects: 0
Study: 32705177

Group type: EXPERIMENTAL
Intervention: CRAS-PCR for TPMT*3 mutations detection
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: DNA sequencing of TPMT*3C MT heterozygotes
Number of subjects: 226
Study: 33966464

Group type: EXPERIMENTAL
Intervention: Regularized optimization problem based on a plug-in image-denoising function using a randomized second order method.
Number of subjects: 0
Study: 32857315

Group type: EXPERIMENTAL
Intervention: Ozanimod 0.46 mg (group A, n = 20)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily for 17 days + ozanimod 0.46 mg on day 4 (group B, n = 20)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ozanimod 0.92 mg (group C, n = 20)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg once daily for 17 days + ozanimod 0.92 mg on day 4 (group D, n = 20)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rifampin 600 mg once daily for 21 days + ozanimod 0.92 mg on day 8 (group E, n = 20)
Number of subjects: 100
Study: 33561819

Group type: EXPERIMENTAL
Intervention: PAUSE
Number of subjects: 26

Group type: COMPARATOR
Intervention: REBOUND
Number of subjects: 26
Study: 32668845

Group type: EXPERIMENTAL
Intervention: Standard treatment for childhood cancer, details on dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: International randomized controlled trials for childhood cancer, details on specific interventions not available.
Number of subjects: 0
Study: 34612612

Group type: EXPERIMENTAL
Intervention: 75% complex motor imagery
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 75% simple motor imagery
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Complex tasks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Rate of imagery (50% vs. 75%)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Task complexity and rate of imagery
Number of subjects: 88
Study: 33055544

Group type: EXPERIMENTAL
Intervention: Gum chewing (mint-flavored sugar-free gum) for 20 minutes every 2 hours until colonoscopy after consuming 2 L of polyethylene glycol solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polyethylene glycol solution (control group)
Number of subjects: 60
Study: 33782936

Group type: EXPERIMENTAL
Intervention: Isometric calf muscle exercise with knee fully extended
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isometric calf muscle exercise with knee flexed to 80°
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comparison of knee extension vs knee flexion
Number of subjects: 11
Study: 32762708

Group type: EXPERIMENTAL
Intervention: C7-T1 Maitland mobilization
Number of subjects: 42

Group type: COMPARATOR
Intervention: Mid-thoracic (T3-T6) manipulation
Number of subjects: 42
Study: 34779392

Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch with newly sourced adhesive component at end of shelf life (EOSL)
Number of subjects: 68

Group type: COMPARATOR
Intervention: EVRA patch at beginning of shelf life (BOSL)
Number of subjects: 68
Study: 34423501

Group type: EXPERIMENTAL
Intervention: Radium-223 plus Enzalutamide
Number of subjects: 47

Group type: COMPARATOR
Intervention: Enzalutamide alone
Number of subjects: 47
Study: 33350732

Group type: EXPERIMENTAL
Intervention: WeChat-based multimodal nursing program and routine nursing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 0
Study: 34309426

Group type: EXPERIMENTAL
Intervention: 0.18-mg fluocinolone acetonide insert
Number of subjects: 129

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 129
Study: 32163038

Group type: EXPERIMENTAL
Intervention: Voice-based VR ACLS team leader refresher
Number of subjects: 25

Group type: COMPARATOR
Intervention: HFS (high-fidelity simulation)
Number of subjects: 25
Study: 35139273

Group type: EXPERIMENTAL
Intervention: Cemiplimab (350 mg every 3 weeks)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice of single-agent chemotherapy)
Number of subjects: 608
Study: 34325519

Group type: EXPERIMENTAL
Intervention: Indexed minimal left atrial volume (LAVImin)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Indexed maximal left atrial volume
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: LA emptying fraction and LA strain
Number of subjects: 347
Study: 34617567

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 139
Study: 34918632

Group type: EXPERIMENTAL
Intervention: Training group (TG) - participated in the entire curriculum training consisting of 48 different VR-simulator tasks over a continuous nine-day training session.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG) - performed two of the VR-simulator tasks on day 1 and 9.
Number of subjects: 60
Study: 35915917

Group type: EXPERIMENTAL
Intervention: Benson's Relaxation, performed twice a day for 10 minutes for 8 weeks after a training session
Number of subjects: 36

Group type: COMPARATOR
Intervention: Educational session about Progressive Relaxation
Number of subjects: 36
Study: 33450639

Group type: EXPERIMENTAL
Intervention: External focus of attention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Real World (RW)
Number of subjects: 56
Study: 34415011

Group type: EXPERIMENTAL
Intervention: portion-controlled meals (PCM)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: acceptance-based treatment (ABT)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Early TRA PCM
Number of subjects: 468

Group type: COMPARATOR
Intervention: Late TRA PCM
Number of subjects: 468
Study: 34375712

Group type: EXPERIMENTAL
Intervention: Music therapy (MT) with imbedded 10 Hz binaural beats combined with standard treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 18
Study: 32839498

Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 7332

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 7332

Group type: COMPARATOR
Intervention: Nomogram based on TNM stage
Number of subjects: 7332
Study: 34009245

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32436800

Group type: EXPERIMENTAL
Intervention: Mobile phone-assisted postpartum family planning service (including contraceptive counselling and two reminders)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (received contraceptive counselling but no mobile phone reminders)
Number of subjects: 1000
Study: 35331191

Group type: EXPERIMENTAL
Intervention: Mindfulness-based self-help IMI
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)-based self-help IMI
Number of subjects: 210

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 210
Study: 32986271

Group type: EXPERIMENTAL
Intervention: Point transect method
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Traditional point-count method with fixed-radius listening areas
Number of subjects: 7000

Group type: EXPERIMENTAL
Intervention: New method of analysis of singing probability per day (p[1])
Number of subjects: 7000
Study: 34001070

Group type: EXPERIMENTAL
Intervention: Fetal growth restriction
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Extremely low birth weight
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Feeding volume < 80 mL/kg/d at the end of the 4th week after birth
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Cholestasis
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Late onset sepsis
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Prolonged (> 2 weeks) diuretics application
Number of subjects: 156
Study: 32674535

Group type: EXPERIMENTAL
Intervention: Strength-oriented training group (STG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ballistic training group (BTG)
Number of subjects: 30